1576 Federal Register / Vol. 89, No. 7 / Wednesday, January 10, 2024 / Notices 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10549 Generic Clearance for 

Questionnaire Testing and 

Methodological Research for the 

Medicare Current Beneficiary Survey 

(MCBS) 

Under the PRA (44 U.S.C. 3501– 

3520), Federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires Federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Extension without change of a 

currently approved collection; Title of 

Information Collection: Generic 

Clearance for Questionnaire Testing and 

Methodological Research for the 

Medicare Current Beneficiary Survey 

(MCBS); Use: The purpose of this OMB 

clearance package is to extend the 

approval of the current generic 

clearance for the Medicare Current 

Beneficiary Survey (MCBS). The MCBS 

Questionnaire Testing and 

Methodological Research encompasses 

development and testing of MCBS 

questionnaires, instrumentation, and 

data collection protocols, as well as a 

mechanism for conducting 

methodological experiments. The 

current clearance includes six types of 

potential research activities: (1) 

cognitive interviewing, (2) focus groups, 

(3) usability testing, (4a) field testing 

within the MCBS production 

environment, (4b) field testing as a 

separate data collection effort outside of 

the MCBS production environment, (5) 

respondent debriefings, and (6) research 

about incentives. 

The MCBS is a continuous, 

multipurpose survey of a nationally 

representative sample of aged, disabled, 

and institutionalized Medicare 

beneficiaries. The MCBS, which is 

sponsored by the Centers for Medicare 

& Medicaid Services (CMS), is the only 

comprehensive source of information on 

the health status, health care use and 

expenditures, health insurance 

coverage, and socioeconomic and 

demographic characteristics of the 

entire spectrum of Medicare 

beneficiaries. The core of the MCBS is 

a series of interviews with a stratified 

random sample of the Medicare 

population, including aged and disabled 

enrollees, residing in the community or 

in institutions. Questions are asked 

about enrollees’ patterns of health care 

use, charges, insurance coverage, and 

payments over time. Respondents are 

asked about their sources of health care 

coverage and payment, their 

demographic characteristics, their 

health and work history, and their 

family living circumstances. In addition 

to collecting information through the 

core questionnaire, the MCBS collects 

information on special topics. Form 

Number: CMS–10549 (OMB control 

number: 0938–1275); Frequency: 

Occasionally; Affected Public: 

Individuals or Households; Number of 

Respondents: 11,655; Total Annual 

Responses: 11,655; Total Annual Hours: 

3,947. (For policy questions regarding 

this collection contact William Long at 

410–786–7927.) 

Dated: January 4, 2024. 

William N. Parham, III, 

Director, Division of Information Collections 

and Regulatory Impacts, Office of Strategic 

Operations and Regulatory Affairs. 

[FR Doc. 2024–00270 Filed 1–9–24; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Physician-Focused Payment Model 

Technical Advisory Committee; 

Meetings 

ACTION: Notice of meetings. 

SUMMARY: This notice announces the 

2024 meetings of the Physician-Focused 

Payment Model Technical Advisory 

Committee (PTAC). These meetings 

include deliberation and voting on 

proposals for physician-focused 

payment models (PFPMs) submitted by 

individuals and stakeholder entities and 

may include discussions on topics 

related to current or previously 

submitted PFPMs. All meetings are 

open to the public. 

DATES: The 2024 PTAC meetings will 

occur on the following dates: 

D Monday–Tuesday, March 25–26, 

2024, from 9 a.m. to 5 p.m. ET. 

D Monday–Tuesday, June 10–11, 

2024, from 9 a.m. to 5 p.m. ET. 

D Monday–Tuesday, September 16– 

17, 2024, from 9 a.m. to 5 p.m. ET. 

D Monday–Tuesday, December 2–3, 

2024, from 9 a.m. to 5 p.m. ET. 

Please note that times are subject to 

change. If the times change, the ASPE 

PTAC website will be updated (https:// 

aspe.hhs.gov/ptac-physician-focusedpayment-model-technical-advisorycommittee) and registrants will be 

notified directly via email. 

ADDRESSES: All PTAC meetings will be 

held virtually or in the Great Hall of the 

Hubert H. Humphrey Building, 200 

Independence Avenue SW, Washington, 

DC 20201. 

FOR FURTHER INFORMATION CONTACT: Lisa 

Shats, Designated Federal Officer at 

Lisa.Shats@hhs.gov (202) 875–0938. 

SUPPLEMENTARY INFORMATION: 

Agenda and Comments. PTAC will 

hear presentations on proposed PFPMs 

that have been submitted by individuals 

and stakeholder entities and/or 

discussion on topics related to current 

or previously submitted PFPMs. 

Regarding proposed PFPMs, following 

each presentation, PTAC will deliberate 

on the proposed PFPM. If PTAC 

completes its deliberation, PTAC will 

vote on the extent to which the 

proposed PFPM meets criteria 

established by the Secretary of Health 

and Human Services and on an overall 

recommendation to the Secretary (if 

applicable). Time will be allocated for 

public comments. The agenda and other 

documents will be posted on the PTAC 

section of the ASPE website, https://

aspe.hhs.gov/ptac-physician-focusedpayment-model-technical-advisorycommittee, prior to the meeting. The 

agenda is subject to change. If the 

agenda does change, registrants will be 

notified directly via email, the website 

will be updated, and notification will be 

sent out through the PTAC email 

listserv (https://list.nih.gov/cgi-bin/

wa.exe?A0=PTAC to subscribe). 

Meeting Attendance. These meetings 

are open to the public and may be 

hosted in-person or virtually. We intend 

that in-person meetings will be held in 

the Great Hall of the Hubert H. 

Humphrey Building. The public may 

attend in person, when feasible, 

virtually, or view the meeting via 

livestream at www.hhs.gov/live. 

Information about how to access the 

meeting virtually or via livestream will 

be sent to registrants prior to the 

meeting; and a telephone number will 

be sent to registrants participating via 

the dial-in only option prior to the 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 7 / Wednesday, January 10, 2024 / Notices 1577 

meeting. Space may be limited, and 

registration is preferred. When 

registration opens, a link to the 

registration page will be available at 

https://aspe.hhs.gov/collaborationscommittees-advisory-groups/ptac/ptacmeetings prior to the meeting. 

Registrants will receive a confirmation 

email shortly after completing the 

registration process. 

Special Accommodations. If sign 

language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact 

PTAC@hhs.gov, no later than two weeks 

prior to the scheduled meeting. 

Authority. 42 U.S.C. 1395(ee); section 

101(e)(1) of the Medicare Access and 

CHIP Reauthorization Act of 2015; 

section 51003(b) of the Bipartisan 

Budget Act of 2018. 

PTAC is governed by provisions of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. app.), which sets 

forth standards for the formation and 

use of federal advisory committees. 

Dated: December 29, 2023. 

Miranda Lynch-Smith, 

Deputy Assistant Secretary for Human 

Services Policy, Performing the delegable 

duties of the Assistant Secretary for Planning 

and Evaluation. 

[FR Doc. 2024–00314 Filed 1–9–24; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Cell Biology 

Integrated Review Group; Development—2 

Study Section. 

Date: February 5–6, 2024. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Rass M. Shayiq, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

2359, shayiqr@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; Cellular, 

Molecular and Integrative Reproduction 

Study Section. 

Date: February 6–7, 2024. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW, 

Washington, DC 20015. 

Contact Person: Anthony Wing Sang Chan, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 809K, 

Bethesda, MD 20892, (301) 496–9392, 

chana2@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group; Maximizing Investigators’ 

Research Award B Study Section. 

Date: February 6–7, 2024. 

Time: 9:30 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sudha Veeraraghavan, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4166, 

MSC 7846, Bethesda, MD 20892, (301) 827– 

5263, sudha.veeraraghavan@nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group; Biobehavioral Mechanisms of 

Emotion, Stress and Health Study Section. 

Date: February 6–7, 2024. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Brittany L. Mason-Mah, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1000A, 

Bethesda, MD 20892, (301) 594–3163, 

masonmahbl@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 4, 2024. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–00294 Filed 1–9–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Biomarkers of 

Cognitive Decline. 

Date: March 27, 2024. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Gianina Ramona 

Dumitrescu, Ph.D., MPH, Scientific Review 

Officer, National Institute on Aging, National 

Institutes of Health, Gateway Building, Suite 

2N300, 7201 Wisconsin Avenue, Bethesda, 

MD 28092, 301–827–0696, dumitrescurg@

.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: January 4, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–00291 Filed 1–9–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Secretary; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Interagency Autism 

Coordinating Committee, January 24, 

2024, 9:00 a.m. to January 24, 2024, 5:00 

p.m., National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 which 

was published in the Federal Register 

on November 8, 2023, FR Doc. No. 

2023–24705, 88 FR 77102. 


lotter on DSK11XQN23PROD with NOTICES1